Showing 121 - 140 results of 156 for search '"Lynching"', query time: 0.09s Refine Results
  1. 121
  2. 122
  3. 123

    High speciation in the cryptic Pristimantis celator clade (Anura: Strabomantidae) of the Mira river basin, Ecuador-Colombia by Mario H. Yánez-Muñoz, Juan P. Reyes-Puig, Carolina Reyes-Puig, Gabriela Lagla-Chimba, Christian Paucar-Veintimilla, Miguel A. Urgiles-Merchán, Julio C. Carrión-Olmedo

    Published 2025-01-01
    “…We propose renaming the group Pristimantis celator clade within Pristimantis myersi species group and subgenus Trachyphrynus, aligning with phylogenetic evidence and resolving taxonomic ambiguities using the oldest available name, Pristimantis celator (Lynch, 1976). This reclassification includes 14 species, seven formally described, and seven as candidates, distributed across northwestern Ecuador and southwestern Colombia, particularly in Mira and Esmeraldas River basins. …”
    Get full text
    Article
  4. 124

    二代测序在子宫内膜癌分子分型的临床应用 by 刘叶, 刘小云, 颜淑梅, 龙亚康, 王海云, 王芳

    Published 2023-03-01
    “…结论对子宫内膜癌进行二代测序,可同时获悉其分子分型各项指标,有效筛查Lynch综合征、各亚型分子变异谱、为免疫治疗及靶向治疗提供指导,并有助于分子遗传特征的进一步积累及探索。…”
    Get full text
    Article
  5. 125
  6. 126
  7. 127

    Integrating BRCA testing into routine prostate cancer care: a multidisciplinary approach by SIUrO and other Italian Scientific Societies by Giulia Mammone, Simona Borghesi, Nicolò Borsellino, Anna Caliò, Roberta Ceccarelli, Alessia Cimadamore, Giario Natale Conti, Laura Cortesi, Rolando Maria D’Angelillo, Gaetano Facchini, Lorena Incorvaia, Alberto Lapini, Luigi Mearini, Giovanni Pappagallo, Paolo Prontera, Daniela Turchetti, Grazia Sirgiovanni, Sergio Bracarda, on behalf of the Italian Society of Uro-Oncology (SIUrO)

    Published 2025-01-01
    “…Abstract Prostate cancer (PCa) ranks among the most prevalent malignancies in men, with notable associations to Hereditary Breast and Ovarian Cancer Syndrome (HBOC) and Lynch Syndrome, both linked to germline likely pathogenetic variant/pathogenetic variant (LPV/PV) in genes involved in DNA repair. …”
    Get full text
    Article
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137

    Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study by Bacharach J, Sadri E, Sawhney G, Kopczynski C, Merchea MM

    Published 2025-01-01
    “…Jason Bacharach,1 Ehsan Sadri,2 Gagan Sawhney,3 Casey Kopczynski,4 Mohinder M Merchea4 1North Bay Eye Associates, Inc, Petaluma, CA, USA; 2Visionary Eye Institute, Newport Beach, CA, USA; 3Georgia Eye Partners, Atlanta, GA, USA; 4Alcon, Inc, Fort Worth, TX, USACorrespondence: Jason Bacharach, North Bay Eye Associates, Inc, 104 Lynch Creek Way, Suite 15, Petaluma, CA, USA, Tel +1(707) 762-3573, Fax +1 (707) 762-6873, Email jbacharach@northbayeye.comPurpose: To determine the effect on intraocular pressure (IOP) of switching to a once-daily netarsudil/latanoprost fixed dose combination (FDC) from various topical treatment regimens including latanoprost monotherapy or latanoprost combined with other IOP-lowering agents for the treatment of open-angle glaucoma or ocular hypertension.Methods: A total of 136 participants enrolled. …”
    Get full text
    Article
  18. 138
  19. 139
  20. 140